Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic (active substance) - analogs
Pharmgroups: Vaccines, serums, phages and toxoids |
|||||||||
| Prices in pharmacies: Instructions Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic included in the composition |
Prices in pharmacies |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 40% Vaccine Meningococcal (groups A, C) polysaccharide prophylactica
- 40% Vaccine Meningococcal (groups A, C, W, Y) polysaccharide prophylactica
- 40% Remedy for diagnostic of meningococcal infections
- 28% Vaccine meningococcae
- 15% Measles vaccine
- 14% Vaccinum ad prophylaxim encephalomyelitis
- 12% Vaccine tick-borne encephalitis
- 11% Interferon beta-1a
- 10% Selegiline
- 10% Levodopa
- 10% Ropinirole
- 10% Tetrabenazine
- 10% Ocrelizumab
- 10% Rifampicin
- 10% Peginterferon beta-1a
- 10% Laquinimod
- 10% Glatiramer acetate
Learn more about the selection of analogues
- The drug has «Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic» 17 analogs by action, the most similar - Vaccine Meningococcal (groups A, C) polysaccharide prophylactica .
- Medical online service has selected the best substitutes for Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Vaccine Meningococcal (serogroup B) subunit recombinant prophylactic analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.